📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Curapath

1.1 - Company Overview

Curapath Logo

Curapath

Headquarter: Spain
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of polymer and lipid-based drug delivery systems—including polymer and lipid nanoparticles—offering custom design through preclinical development to commercial-scale pharmaceutical manufacturing, plus drug conjugation and cross-linking services to enhance stability, reduce toxicity, and improve bioactivity.

Products and services

  • Custom Design to Preclinical Development through Commercial-Scale Pharmaceutical Manufacturing: Curapath architects custom design to preclinical development through commercial-scale pharmaceutical manufacturing, spanning services from custom design and preclinical development to commercial-scale pharmaceutical manufacturing
  • Drug Conjugation and Cross-Linking: Curapath develops custom-chemistry drug conjugation and cross-linking services to enhance drug stability, reduce toxicity, and improve bioactivity
  • Polymer and Lipid-Based Drug Delivery Systems: Curapath engineers custom-engineered polymer and lipid-based drug delivery systems, including polymer nanoparticles and lipid nanoparticles, covering design, development, and manufacturing

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Curapath

EMD Millipore Logo

EMD Millipore

HQ: United States Website
  • Description: Provider of biopharmaceutical manufacturing solutions including cell culture media, filtration and purification systems; life science research tools and reagents for genomic analysis, protein sample preparation, antibodies, assays and small molecule research; laboratory water purification systems and consumables; microbial testing for pharma, cosmetics, food, beverages and municipal water; IVD/OEM kits, materials and reagents; and chemicals, reagents and labware.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full EMD Millipore company profile →
CPH Logo

CPH

HQ: Switzerland Website
  • Description: Provider of chemical manufacturing and paper and packaging products for the chemical industries, serving the chemistry, paper, and packaging sectors.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CPH company profile →
Avid Bioservices Logo

Avid Bioservices

HQ: United States Website
  • Description: Provider of end-to-end biologics services, including mammalian protein process development, drug substance development, CGMP manufacturing from early stages to commercial scale, and analytical services; also specializes in viral vector design, optimization, and scalable production for gene therapy and vaccine applications. Expansion doubles capacity to service a $40m backlog and support owner Peregrine.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Avid Bioservices company profile →
Bolder BioPath Logo

Bolder BioPath

HQ: United States Website
  • Description: Provider of pharmacology and pathology services.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Bolder BioPath company profile →
Syntactx Logo

Syntactx

HQ: United States Website
  • Description: Provider of global clinical research services specializing in complex clinical trials, offering consulting across all phases, biostatistics and statistical programming, clinical evidence and post-market studies, clinical trial safety with in-house medical monitors and MeDRA coders, data management and EDC, and field clinical engineering staffing.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Syntactx company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Curapath

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Curapath

2.2 - Growth funds investing in similar companies to Curapath

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Curapath

4.2 - Public trading comparable groups for Curapath

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Curapath

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Curapath

What does Curapath do?

Curapath is a provider of polymer and lipid-based drug delivery systems—including polymer and lipid nanoparticles—offering custom design through preclinical development to commercial-scale pharmaceutical manufacturing, plus drug conjugation and cross-linking services to enhance stability, reduce toxicity, and improve bioactivity.

Who are Curapath's competitors?

Curapath's competitors and similar companies include EMD Millipore, CPH, Avid Bioservices, Bolder BioPath, and Syntactx.

Where is Curapath headquartered?

Curapath is headquartered in Spain.

How many employees does Curapath have?

Curapath has 1,000 employees 🔒.

When was Curapath founded?

Curapath was founded in 2010 🔒.

What sector and industry vertical is Curapath in?

Curapath is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Curapath

Who are the top strategic acquirers in Curapath's sector and industry

Top strategic M&A buyers and acquirers in Curapath's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Curapath?

Top strategic M&A buyers groups and sectors for Curapath include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Curapath's sector and industry vertical

Which are the top PE firms investing in Curapath's sector and industry vertical?

Top PE firms investing in Curapath's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Curapath's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Curapath's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Curapath's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Curapath include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Curapath's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Curapath?

The key public trading comparables and valuation benchmarks for Curapath include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Curapath for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Curapath with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Curapath's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Curapath with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Curapath's' sector and industry vertical?

Access recent funding rounds and capital raises in Curapath's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Curapath